Coronavirus – Page 2 – Medical Alley Association


Health Care Communications In The Age Of COVID-19: Lessons From Mayo Clinic

Via Padilla “As we all know, health care media relations on a normal day can be challenging. Before COVID-19, “normal” for Mayo Clinic looked like this: 25-30 media calls per day; handled by a team of more than 20 Daily proactive media efforts (story pitching, issuing press releases and media advisories, etc.) Coordinating interviews with Mayo Clinic […]

Abbott Announces Health Canada Authorization Under the COVID-19 Interim Order and Immediate Availability of its COVID-19 Antibody Test in Canada

Via Abbott Abbott (NYSE: ABT) announced today it received Health Canada authorization under the COVID-19 Interim Order* for the ARCHITECT SARS-CoV-2 IgG test, a laboratory-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19). Antibody testing is an important next step to tell […]

Osterholm Update: COVID-19

Via University of Minnesota In this episode, Dr. Osterholm and host Chris Dall discuss the concept of smart testing, the risk of transmission outdoors, reports of children developing an inflammatory condition following infection with COVID-19, and the CDC’s role in this pandemic. Listen to the latest episode of Dr. Michael Osterholm’s podcast or read the […]

Is History Repeating Itself?

Via Zipnosis “Comparisons between the 1918 pandemic and the era of COVID-19 have been happening since the outbreak began in March. With the striking similarities, it is tempting to look for clues as to how our own pandemic era will progress. Unfortunately, as epidemiologists like to say, “If you’ve seen one pandemic, you’ve seen one pandemic.” […]

Bio-Techne and Kantaro Biosciences Announce Partnership to Develop and Scale Production of COVID-19 Serology Test

Via Bio-Techne  Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai-developed COVID-19 serology test. Kantaro Biosciences is a joint venture between Mount Sinai Health System (“Mount Sinai”) […]

COVID-19 Study Paves the Way for an Innovative Virtual Clinical Trial

Via UnitedHealth Group A study completed by UnitedHealth Group with the Yale School of Medicine found that older COVID-19 patients with hypertension taking angiotensin-converting enzyme (ACE) inhibitors had a lower risk of COVID-19 hospitalization. A pragmatic clinical trial will be a critical next step. Methodology The study, which was recently submitted for peer-reviewed publication, analyzed […]

Research Brief: A new approach to averting inflammation caused by COVID-19

Via University of Minnesota “’We are now recognizing the importance of controlling this robust inflammatory response in COVID-19 infection in order to reduce associated organ damage and mortality,’ said Gilligan, a student at the Medical School. ‘Finding new ways to dampen the body’s inflammatory response to COVID-19 will likely be as important as finding effective […]

Bethesda Hospital doctor on treating COVID-19 patients

Via MPR “Meanwhile, the number of people in intensive care — a key measure of the stress on our healthcare system — has now topped 200 in the state. Many of those patients are being treated at Bethesda Hospital in St. Paul.” “As a COVID-19 specialty center, Bethesda has seen some of the worst of […]

Blue Cross waives more fees for Medicare Advantage customers

Via Star Tribune “‘In the midst of this crisis, seniors have been greatly impacted and are at disproportionate risk,’ Dr. Craig Samitt, chief executive of Blue Cross, said in a statement. ‘With our hope to keep our senior members safe and assure that they receive the preventive care they need, Blue Cross is both expanding […]

Investigators Call for Treatment Centers to Join COVID-19 Global Registry

Via Contagion “Mayo Clinic and the Society of Critical Care Medicine (SCCM) partnered to launch the Viral Infection and Respiratory Illness Universal Study (VIRUS), a global coronavirus disease 2019 (COVID-19) registry which would shed light on varying treatment patterns around the world.” “The registry has gathered information on more than 5000 patients from 81 clinical sites since […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER